Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessing the cardiovascular safety of diabetes therapies.

× No keyword cloud information.

31 in total

1. Controversy about the cardiovascular safety of sibutramine.

Authors: André J Scheen
Journal: Drug Saf Date: 2010-07-01 Impact factor: 5.606

Review 2. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors: Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal: Rev Endocr Metab Disord Date: 2010-03 Impact factor: 6.514

3. Developing therapies for the metabolic syndrome: challenges, opportunities, and… the unknown.

Authors: Glenn Matfin
Journal: Ther Adv Endocrinol Metab Date: 2010-04 Impact factor: 3.565

Review 4. Cardiovascular effects of gliptins.

Authors: André J Scheen
Journal: Nat Rev Cardiol Date: 2013-01-08 Impact factor: 32.419

5. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.

Authors: Minsuk Kim; Mathew J Platt; Tadao Shibasaki; Susan E Quaggin; Peter H Backx; Susumu Seino; Jeremy A Simpson; Daniel J Drucker
Journal: Nat Med Date: 2013-03-31 Impact factor: 53.440

6. Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database.

Authors: Sunghwan Suh; Gi Hyeon Seo; Chang Hee Jung; Mee-Kyoung Kim; Sang-Man Jin; You-Cheol Hwang; Byung-Wan Lee; Jae Hyeon Kim
Journal: Diabetes Metab J Date: 2015-04-22 Impact factor: 5.376

Assessing the cardiovascular safety of diabetes therapies.

1. Controversy about the cardiovascular safety of sibutramine.

Review 2. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

3. Developing therapies for the metabolic syndrome: challenges, opportunities, and… the unknown.

Review 4. Cardiovascular effects of gliptins.

5. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.

6. Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database.

Review 7. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

Review 8. [The unsolved problem of diabetes mellitus type 2 and associated complications].

Review 9. The unrelenting fall of the pharmacological treatment of obesity.

Review 10. Cardiovascular safety of therapies for type 2 diabetes.